Skip to main content

Volume 14 Supplement 6

Viral Hepatitis and Drug Use in Europe

Research and Commentaries

Edited by Jeffrey V Lazarus and Kevin A Fenton

This publication has been produced with the financial support of the Drug Prevention and Information Programme (DPIP) of the European Union. The contents of this publication are the sole responsibility of the authors and can in no way be taken to reflect the view of the European Commission. The publication charges for this supplement were funded by AbbVie as an unresitricted grant to Rigshospitalet, the University of Copenhagen, Denmark. AbbVie further co-funded the printing of the supplement. The peer review process was overseen by the Supplement Editors in accordance with BioMed Central's peer review guidelines for supplements. The Supplement Editors declare that they have no competing interests.

 Read the blog related to this supplement.

  12. Behavioural surveillance among people who inject drugs (PWID) and testing for hepatitis C virus (HCV) and HIV is needed to understand the scope of both epidemics in at-risk populations and to suggest steps to ...

    Authors: Robert Heimer, Ksenia Eritsyan, Russell Barbour and Olga S Levina

    Citation: BMC Infectious Diseases 2014 14(Suppl 6):S12

    Content type: Research

    Published on:

  14. Hepatitis C virus (HCV) infection represents a major global health problem, which in high-income countries now mostly affects people who inject drugs (PWID). Many studies show that the treatment of HCV infecti...

    Authors: Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz and Jeffrey V Lazarus

    Citation: BMC Infectious Diseases 2014 14(Suppl 6):S14

    Content type: Research

    Published on:

  15. Unsafe injections, through infectious bodily fluids, are a major route of transmission for hepatitis B and C. Viral hepatitis burden among people who inject drugs is particularly high in many Member States of ...

    Authors: Alexander Spina, Irina Eramova and Jeffrey V Lazarus

    Citation: BMC Infectious Diseases 2014 14(Suppl 6):S15

    Content type: Research

    Published on:

  16. Fifteen million adults in the World Health Organization European Region are estimated to have active hepatitis C infection. Intravenous drug use is a major hepatitis C transmission route in this region, and pe...

    Authors: Jeffrey V Lazarus, Ida Sperle, Mojca Maticic and Lucas Wiessing

    Citation: BMC Infectious Diseases 2014 14(Suppl 6):S16

    Content type: Research

    Published on:

  18. Authors: Jeffrey V Lazarus, Jens Lundgren, Jordi Casabona, Lucas Wiessing, Catharina Matheï, Peter Vickerman, Maria Prins, Mirjam Kretzschmar, Maria Kantzanou, Isabelle Giraudon, Marica Ferri, Paul Griffiths, Magdalena Harris, Margaret Walker, Lilyana Chavdarova, Eberhard Schatz…

    Citation: BMC Infectious Diseases 2014 14(Suppl 6):S18

    Content type: Roundtable

    Published on:

Submit manuscript

Annual Journal Metrics

Follow

COVID-19 Announcement

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

BMC Infectious Diseases

ISSN: 1471-2334

Contact us